Top of this page
Skip navigation, go straight to the content
Categories
-
A portrait of ‘Epilepsy in Our Time’
Posted by Eimear O'Brien, Brand Communications 13-Feb-2012
-
Sharing the good news…
Posted by Antje Witte, Investor Relations 23-Jan-2012
Where did the Christmas holidays go? Somehow it’s almost February already but at least January brought a major piece of good news: we won an award!
-
‘Closing the Gap’ at Christmas time
Posted by Isabelle de Cambry, Corporate Social Responsibility 21-Dec-2011
With Christmas just days away, UCB is donating nine pallets of used ICT equipment to the Close the Gap campaign.
-
UCB: always listening
Posted by France Nivelle, Global Communications & Change Support 06-Dec-2011
Here at UCB, we listen. We listen to patients, we listen to health care professionals, we listen to investors and we listen to our colleagues.
-
Big plans for industrial scale biotech plant
Posted by Nicolas Tièche, Coordination Mgr Bioplant Switzerland 05-Dec-2011
Exciting times. Every day we move a step closer to building our new biotechnology production unit in Bulle, Switzerland. Three weeks ago we presented the architectural design and two weeks ago we submitted the building permit application to authorities. The construction will start in early 2012.
-
Summit brings together movement and sleep disorder specialists
Posted by Eimear O'Brien, CNS Communications 30-Nov-2011
-
Strategic partnerships to further strengthen R&D
Posted by Antje Witte, Investor Relations 25-Nov-2011
UCB has just finalised some major strategic partnerships which will pave the way for more efficient preclinical research and clinical development.
-
Welcome to the UCB Press Centre 2.0
Posted by Cindy Maas, Media Relations 25-Nov-2011
We believe good news is for sharing, so we’ve revamped our online Media Room on UCB.com to make it more social media-friendly.
-
UCB’s CSR programme makes an appearance in Beijing
Posted by Isabelle de Cambry, Corporate Social Responsibility 22-Nov-2011
UCB’s support for a new epilepsy unit in China is just the latest example of our efforts to improve the lives of patients and communities.
-
Final call: last chance to enter epilepsy journalism award
Posted by Eimear O'Brien, CNS Communications 09-Nov-2011
-
Q3 financial results show UCB is on track
Posted by Antje Witte, Investor Relations 27-Oct-2011
-
UCB.com: listening to you
Posted by Nathalie Vandenbruaene, Global Digital Operations 27-Oct-2011
Here at UCB we’re always trying to improve our website. And, thanks to you, we’re moving in the right direction. -
New bio plant on the horizon
Posted by Stefanos Ioannis Grammatikos, Biological Process Development 14-Oct-2011
A new chapter in UCB’s history will soon be written: by the end of 2012, we will open our first UCB-owned biologics pilot plant in Braine. -
World Arthritis Day: Helping patients ‘Get to Goal’
Posted by Scott Fleming, Global Communications, Immunology 12-Oct-2011
UCB is launching a new campaign to help patients with rheumatoid arthritis to play a more active role in managing their disease. -
Champion cyclist shares inspiring epilepsy story
Posted by Lesley McMenamin, Business Unit CNS, UCB Australia 07-Oct-2011
Six-time World Champion cyclist, Marion Clignet, is living proof of what can be achieved by people living with epilepsy. -
UCB 'on the road again'
Posted by Antje Witte, Investor Relations 13-Sep-2011
-
Breaking the stigma of epilepsy – one story at a time
Posted by Eimear O'Brien, CNS Communications 08-Sep-2011
The Excellence in Epilepsy Journalism Award has created a virtuous cycle by encouraging top health journalists to deepen public understanding of epilepsy.
-
Countdown is on to Epilepsy Journalism Award
Posted by Eimear O'Brien, CNS Communications 01-Sep-2011
Calling all health and medical journalists who have written or broadcast about epilepsy! -
UCB: Committed to epilepsy care
Posted by Eimear O'Brien, CNS Communications 01-Sep-2011
-
Europe can innovate its way to growth
Posted by France Nivelle, Global Communications & Change Support 10-Aug-2011
-
UCB delivers strong results
Posted by Antje Witte, Investor Relations 29-Jul-2011
-
UCB in Washington DC: Bio, FDA, NIH with the support of HRH Prince Philippe of Belgium
Posted by France Nivelle, Global Communications & Change Support 15-Jul-2011
-
An Osteoporosis Odyssey
Posted by Antje Witte, Investor Relations 13-Jul-2011
What have bone research, and NASA got in common? -
Brain power: UCB joins forces with Harvard
Posted by France Nivelle, Global Communications & Change Support 13-Jul-2011
What do you get when you cross a global biopharma leader with one of the world’s most prestigious universities? -
Parkinson’s disease has many dimensions
Posted by Eimear O'Brien, CNS Communications 13-Jul-2011
-
Lupus: hitting patients’ careers
Posted by Scott Fleming, Global Communications, Immunology 08-Jul-2011
An interesting new pan-European study puts numbers on something that has been suspected for some time: Lupus has a negative impact on patients’ working life. -
And the winner is…
Posted by Henrik Klitgaard, CNS Research 07-Jul-2011
Here at UCB, we are always delighted to see excellent researchers recognised for their valuable work. -
*Update* ‘Carpooling for Cargo’ wins top prize
Posted by Cindy Maas, Media Relations 07-Jul-2011
-
For rheumatoid arthritis patients, goals and targets count
Posted by Scott Fleming, Global Communications, Immunology 04-Jul-2011
Here’s an interesting study that caught my eye at a recent conference. It shows that people with rheumatoid arthritis (RA) believe that personalised goal setting can have a positive impact on their disease management.
-
UCB at the International Congress of Parkinson's Disease & Movement Disorders
Posted by O'Brien Eimear, CNS Communications 14-Jun-2011
UCB was present last week (June 5-9 2011) at the 15th International Congress of Parkinson’s Disease & Movement Disorders which was held in Toronto Canada.
-
Today I will...
Posted by Eimear O'Brien, CNS Communications 27-May-2011
For people living with Parkinson’s disease, it can help to hear from others facing similar challenges. -
Carpooling for Cargo
Posted by Nancy Nackaerts, Corporate External Communications 27-May-2011
UCB has joined forces with Baxter to create the world’s first ‘carpooling for cargo’ community. -
World Crohn’s Day
Posted by Scott Fleming, Global Communications, Immunology 23-May-2011
Today, on World Crohn’s Day, we turn the spotlight on a chronic disorder that causes inflammation of the gastrointestinal tract. -
UCB backs biking against rheumatism
Posted by Scott Fleming, Global Communications, Immunology 20-May-2011
A team of patients and doctors, along with representatives of NGOs and industry, are set to cycle from Brussels to London to raise awareness of rheumatism in Europe -
2011 Excellence in Epilepsy Journalism Award
Posted by Eimear O'Brien, CNS Communications 19-May-2011
UCB and the International Bureau for Epilepsy (IBE) are pleased to launch the 2011 Excellence in Epilepsy Journalism Award. -
World Lupus Day 2011
Posted by Scott Fleming, Global Communications, Immunology 10-May-2011
UCB is committed to improving the lives of people with lupus and supports the World Lupus Day -
Patient group honours UCB CEO
Posted by Scott Fleming, Global Communications, Immunology 10-May-2011
The Lupus Foundation of America (LFA) is to present Dr Roch Doliveux, Chief Executive Officer of UCB, with its National Leadership in Patient Advocacy Award. -
Lupus Media Centre
Posted by Scott Fleming, Global Communications, Immunology 10-May-2011
UCB launches Lupus Media CentreWe are delighted to announce the launch of the Systemic Lupus Erythematosus (SLE or lupus) media centre on UCB.com.
-
UCB at the American Academy of Neurology congress, April, 9-16
Posted by Eimear O'Brien, CNS Communications 03-May-2011
UCB had a strong presence at the American Academy of Neurology (AAN) Annual Meeting in Hawaii, USA, with new research findings unveiled through a series of presentations -
UCB off to good start in 2011
Posted by Antje Witte, Investor Relations 29-Apr-2011
Financial figures published on April, 28 reveal UCB got off to a strong start with total revenue increasing by 13% to €893 million in the first quarter of the year. -
2010 Annual Report
Posted by Antje Witte, Investor Relations 29-Apr-2011
Annual Report shows UCB’s biopharma aspirations on trackThe 2010 Annual Report is now available on the UCB website. Offering more than just financial results, this year’s report highlights and analyses UCB’s 2010 activities as it advanced its goals of becoming the patient-centric biopharmaceutical leader.
